Bibliographic Details
| Title: |
Retraction: Pioglitazone, a PPARγ Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1. |
| Authors: |
Subbaramaiah K, Howe LR, Zhou XK, Yang P, Hudis CA, Kopelovich L, Dannenberg AJ |
| Source: |
Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2022 Jun 02; Vol. 15 (6), pp. 411. |
| Publication Type: |
Journal Article; Retraction Notice |
| Journal Info: |
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE; PubMed not MEDLINE |
| Database: |
MEDLINE Ultimate |
